Crucial medicines added to the list of medicines that cannot be parallel exported from the UK

Crucial medicines added to the list of medicines that cannot be parallel exported from the UK

March 20, 2020

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that over 80 medicines are to be added to the list of medicines which must not be parallel exported from the UK. The restriction will be in place from 00:00am 21 March 2020.

The parallel export ban will help ensure there is an uninterrupted supply of medicines for NHS hospitals treating COVID-19 patients.

The new restrictions cover crucial medicines such as:

  • adrenaline
  • insulin
  • paracetamol
  • morphine

View the latest list of medicines that cannot be parallel exported from the UK (updated 20/03/20)

The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.



Posted in: , ,


More Latest News >

Funding for Easter opening hours

Further to NHS England and NHS Improvement’s (NHSE&I) decision that community pharmacies in England must open between 2pm and 5pm...